Beacon Diagnostics, Inc. Announces Cyprus Distribution Agreement.FOSTER CITY, Calif.--(BUSINESS WIRE)--July 19, 1995--Beacon Diagnostics, Inc. announced today that it has entered into a distribution agreement with Hard Rock Consultants, a member of the Hadjimichael Group of Companies, for distribution of the OraScreen(TM) HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. Rapid Test in Cyprus. The three year exclusive agreement commits Hard Rock to purchase a minimum of $2.8 million of diagnostic kits from Beacon. Dr. Jerome Mattingly, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Beacon Diagnostics, stated, "Beacon is very enthusiastic about establishing a distribution relationship with Hard Rock. As a member of the Hadjimichael Group, they have an outstanding ability to market a wide range of products within Cyprus. Beacon and Hard Rock form a natural synergy that will complement our worldwide marketing strategy." Abraham Hadjimichael, Managing Director of Hard Rock, commented, "We are pleased to be able to work with Beacon to launch their exciting new product in our market. The OraScreen(TM) HIV Rapid Test has excellent sensitivity and specificity and will be a great success here. We plan to develop innovative channels for the OraScreen(TM) HIV Rapid Test which will allow visitors as well as our own citizens to have access to this simple and highly reliable method for detection of antibodies to HIV." The OraScreen(TM) HIV Rapid Test is a 15 minute "dipstick dipstick /dip·stick/ (dip´stik) a strip of cellulose chemically impregnated to render it sensitive to protein, glucose, or other substances in the urine. " style test to detect HIV antibodies HIV antibody A self antibody specifically directed against one or more proteins or antigens on the surface of HIV, which may be minimally protective against HIV in saliva saliva Thick, colourless fluid constantly present in the mouth, composed of water, mucus, proteins, mineral salts, and amylase, an enzyme that breaks down starches. One to two litres are produced daily by the salivary glands. . The sensitivity and specificity of the Beacon saliva based test are similar to those of blood based tests. The kit is complete with the saliva collector and all reagents necessary to perform the test and interpret the results. Beacon Diagnostics, Inc. is a privately held development stage company engaged in the development, production and marketing of rapid, non-invasive, in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic test systems for infectious diseases infectious diseases: see communicable diseases. . The Company was founded in 1991 as Oracle Diagnostics, Inc., and recently announced a change of name to Beacon Diagnostics, Inc. CONTACT: Beacon Diagnostics, Inc., Foster City Dr. Jerome Mattingly, 415/574-4800 (Tel.) or 415/574-3215 (Fax) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion